BioCentury
ARTICLE | Clinical News

KC706: Phase I data

August 28, 2006 7:00 AM UTC

Data from 3 Phase I trials in a total of 79 health volunteers showed that KC706 was safe and well tolerated and confirmed the bioavailability of the compound in a capsule formulation. ...